Overexpression of Substance P in pig airways increases MUC5AC through an NF-kβ pathway

Mariana Sponchiado1, Yan-Shin Liao1, Kalina R Atanasova1,2

  • 1Department of Physiological Sciences, University of Florida, Gainesville, FL, USA.

Physiological Reports
|February 13, 2021
PubMed

Insights

Overexpression of Substance P (SP) increases MUC5AC, a key mucin, in airways by activating the NF-κβ pathway. This occurs even without inflammation, highlighting SP

Area of Science:

  • Pulmonary Medicine
  • Cellular Biology
  • Molecular Signaling

Background:

  • Substance P (SP) is a neuropeptide regulating airway mucus secretion.
  • Its role in initiating mucus changes without inflammation is unclear.
  • Mucin overproduction contributes to airway obstruction.

Purpose of the Study:

  • To investigate if Substance P overexpression alone induces airway mucus changes.
  • To elucidate the signaling pathways involved in SP-mediated mucus secretion.
  • To assess the impact on mucociliary transport.

Main Methods:

  • Porcine precision-cut lung slices (PCLS) were used for ex vivo studies.
  • Adeno-associated virus (AAV) mediated SP overexpression.
  • Immunofluorescence for MUC5AC and MUC5B, IL10 mRNA levels, and mucociliary transport were measured.
  • NF-κβ pathway inhibition was employed.

Main Results:

  • SP overexpression significantly increased MUC5AC levels but not MUC5B.
  • IL10 mRNA expression was decreased in SP-overexpressing PCLS.
  • A trend for reduced mucociliary transport speed was observed under methacholine challenge.
  • NF-κβ pathway inhibition abolished SP-induced MUC5AC and IL10 changes.

Conclusions:

  • Substance P overexpression, independent of inflammation, drives MUC5AC increase via NF-κβ activation.
  • SP is a significant factor in abnormal airway mucus secretion.
  • NF-κβ signaling represents a potential therapeutic target for mucus-related airway diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.6K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
861
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
887
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
802